165 related articles for article (PubMed ID: 14706012)
1. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
Int J Urol; 2004 Feb; 11(2):88-96. PubMed ID: 14706012
[TBL] [Abstract][Full Text] [Related]
2. [Effect of distigmine at 5 mg daily in patients with detrusor underactivity].
Sugaya K; Kadekawa K; Onaga T; Ashitomi K; Mukouyama H; Nakasone K; Shimabukuro H; Shimabukuro S; Matayoshi Y; Hokama S; Touyama Y; Nishijima S
Nihon Hinyokika Gakkai Zasshi; 2014 Jan; 105(1):10-6. PubMed ID: 24605581
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic drugs for treatment of recurrent urinary retention in high surgical risk/elderly BPH patients. A pilot study.
Skolarikos A; Tyritzis S; Stamatiou K
Minerva Urol Nefrol; 2012 Sep; 64(3):209-16. PubMed ID: 22971686
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of solifenacin plus tamsulosin OCAS in men with voiding and storage lower urinary tract symptoms: results from a phase 2, dose-finding study (SATURN).
Van Kerrebroeck P; Haab F; Angulo JC; Vik V; Katona F; Garcia-Hernandez A; Klaver M; Traudtner K; Oelke M
Eur Urol; 2013 Sep; 64(3):398-407. PubMed ID: 23537687
[TBL] [Abstract][Full Text] [Related]
5. Zolpidem pharmacotherapy combined with alpha-blocker therapy for nocturia unresponsive to alpha-blocker monotherapy in men with lower urinary tract symptoms: a preliminary study.
Song YS; Ku JH
Int Urol Nephrol; 2007; 39(4):1147-52. PubMed ID: 17610040
[TBL] [Abstract][Full Text] [Related]
6. Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
Yan M; Xue P; Wang K; Gao G; Zhang W; Sun F
Strahlenther Onkol; 2017 Sep; 193(9):714-721. PubMed ID: 28612083
[TBL] [Abstract][Full Text] [Related]
7. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
Vanderbrink BA; Gitlin J; Toro S; Palmer LS
J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
[TBL] [Abstract][Full Text] [Related]
8. Alpha blocker therapy for children with dysfunctional voiding and urinary retention.
Cain MP; Wu SD; Austin PF; Herndon CD; Rink RC
J Urol; 2003 Oct; 170(4 Pt 2):1514-5; discussion 1516-7. PubMed ID: 14501648
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled study.
Yokoyama T; Kumon H; Nasu Y; Takamoto H; Watanabe T
Int J Urol; 2006 Jul; 13(7):932-8. PubMed ID: 16882058
[TBL] [Abstract][Full Text] [Related]
10. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study.
Yucel S; Akkaya E; Guntekin E; Kukul E; Akman S; Melikoglu M; Baykara M
J Urol; 2005 Oct; 174(4 Pt 2):1612-5; discussion 1615. PubMed ID: 16148665
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms.
Ozdemir I; Bozkurt O; Demir O; Aslan G; Esen AA
Urology; 2009 Aug; 74(2):431-5. PubMed ID: 19501883
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
[TBL] [Abstract][Full Text] [Related]
13. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
Gotoh M
Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor.
Bougas DA; Mitsogiannis IC; Mitropoulos DN; Kollaitis GC; Serafetinides EN; Giannopoulos AM
Int Urol Nephrol; 2004; 36(4):507-12. PubMed ID: 15787326
[TBL] [Abstract][Full Text] [Related]
15. Initial Use of High-Dose Anticholinergics Combined with Alpha-Blockers for Male Lower Urinary Tract Symptoms with Overactive Bladder: A Prospective, Randomized Preliminary Study.
Lee KW; Hur KJ; Kim SH; Cho SY; Bae SR; Park BH; Lee YS; Han CH; Kim HW
Low Urin Tract Symptoms; 2017 Sep; 9(3):129-133. PubMed ID: 27028190
[TBL] [Abstract][Full Text] [Related]
16. A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms.
Cho S; Kwon SS; Lee KW; Yoo TK; Shin DG; Kim SW; Bae JH; Choi H; Kim YH
Int J Clin Pract; 2017 May; 71(5):. PubMed ID: 28508455
[TBL] [Abstract][Full Text] [Related]
17. Naftopidil monotherapy vs naftopidil and an anticholinergic agent combined therapy for storage symptoms associated with benign prostatic hyperplasia: A prospective randomized controlled study.
Maruyama O; Kawachi Y; Hanazawa K; Koizumi K; Yamashita R; Sugimura S; Honda S; Sugiyama Y; Saitoh T; Noto K
Int J Urol; 2006 Oct; 13(10):1280-5. PubMed ID: 17010005
[TBL] [Abstract][Full Text] [Related]
18. [Does alpha1-blocker provide additional improvement of quality-of-life in patients with overactive bladder?--a multi-center prospective randomized trial between anti-cholinergic (propiverine chloride) with and without alpha1-blocker (urapidil)].
Matsuyama H; Shimizu Y; Kamiryo Y; Joko K; Shimabukuro T; Suga A; Takemoto M; Imoto K; Hara Y; Yamamoto N; Kaneda Y; Harada N; Naito K
Nihon Hinyokika Gakkai Zasshi; 2007 May; 98(4):604-13. PubMed ID: 17564103
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
